Elsevier

Surgery

Volume 146, Issue 5, November 2009, Pages 837-840
Surgery

Surgical Research Review
Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: Is it time yet?

https://doi.org/10.1016/j.surg.2009.06.012Get rights and content

First page preview

First page preview
Click to open first page preview

References (16)

There are more references available in the full text version of this article.

Cited by (83)

  • KAMPOmics: A framework for multidisciplinary and comprehensive research on Japanese traditional medicine

    2022, Gene
    Citation Excerpt :

    Today, many scientific papers reporting the benefits of Kampo prescriptions in contemporary medical practices and elucidation of their mechanisms of action have been published. As a result, since the mid-1970 s, numerous pharmaceutical-grade Kampo medicines have been fully integrated into the modern healthcare system in Japan (Tsumura, 1991; Kono et al., 2009; Fuyuno, 2011; Kono et al., 2015; Takayama et al., 2020). Currently, 148 Kampo formulae are officially approved as prescription drugs and covered by the national health insurance system.

  • A prospective single-institute study of the impact of Daikenchuto on the early postoperative outcome after living donor liver transplantation

    2019, Asian Journal of Surgery
    Citation Excerpt :

    DKT is an herbal drug mixture composed of 4 ingredients: Japanese pepper extract, processed ginger, ginseng radix, and maltose powder derived from rice. DKT is well known to stimulate intestinal motility with its action both on sensory neurons of the gut and on non-neuronal tissues,11 and it has been shown to improve several bowel diseases clinically, as mentioned before. DKT also has several positive impacts on the physiology of the liver, including the increase of portal venous flow4,5 and prevention of sinusoidal obstruction syndrome.12

View all citing articles on Scopus
View full text